Page last updated: 2024-11-05

trihexyphenidyl and Dementia

trihexyphenidyl has been researched along with Dementia in 6 studies

Trihexyphenidyl: One of the centrally acting MUSCARINIC ANTAGONISTS used for treatment of PARKINSONIAN DISORDERS and drug-induced extrapyramidal movement disorders and as an antispasmodic.

Dementia: An acquired organic mental disorder with loss of intellectual abilities of sufficient severity to interfere with social or occupational functioning. The dysfunction is multifaceted and involves memory, behavior, personality, judgment, attention, spatial relations, language, abstract thought, and other executive functions. The intellectual decline is usually progressive, and initially spares the level of consciousness.

Research Excerpts

ExcerptRelevanceReference
"There is a discrepancy in the decisions on the marketing authorization vs the reimbursement in Lithuania and Latvia (reimbursement of haloperidol and trihexyphenidyl for the off-label treatment of dementia)."5.01Off-Label Use of Antipsychotic Agents in Dementia: Evidence for the Revision of the Reimbursement Policy. ( Jankūnas, RJ; Lesauskaitė, V; Stakišaitis, D; Zamarytė-Sakavičienė, K, 2019)

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19903 (50.00)18.7374
1990's1 (16.67)18.2507
2000's1 (16.67)29.6817
2010's1 (16.67)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Stakišaitis, D1
Zamarytė-Sakavičienė, K1
Lesauskaitė, V1
Jankūnas, RJ1
Preskorn, SH1
Nishiyama, K1
Mizuno, T1
Sakuta, M1
Kurisaki, H1
Fine, F1
Walker, DJ1
Gol'dovskaia, IL1
Powell, HC1
London, GW1
Lampert, PW1

Reviews

1 review available for trihexyphenidyl and Dementia

ArticleYear
Off-Label Use of Antipsychotic Agents in Dementia: Evidence for the Revision of the Reimbursement Policy.
    Therapeutic innovation & regulatory science, 2019, Volume: 53, Issue:4

    Topics: Antipsychotic Agents; Dementia; European Union; Haloperidol; Humans; Insurance, Health, Reimbursemen

2019

Other Studies

5 other studies available for trihexyphenidyl and Dementia

ArticleYear
Multiple medication use presenting as Parkinson's dementia complex: a message from Titanic.
    Journal of psychiatric practice, 2008, Volume: 14, Issue:1

    Topics: Aged; Anti-Infective Agents; Antiparkinson Agents; Antipsychotic Agents; Bacteriuria; Ciprofloxacin;

2008
Chronic dementia in Parkinson's disease treated by anticholinergic agents. Neuropsychological and neuroradiological examination.
    Advances in neurology, 1993, Volume: 60

    Topics: Aged; Biperiden; Blood Glucose; Brain; Cerebral Cortex; Dementia; Energy Metabolism; Female; Humans;

1993
Management of the elderly agitated demented patient.
    British medical journal, 1977, Aug-27, Volume: 2, Issue:6086

    Topics: Aged; Anti-Anxiety Agents; Dementia; Drug Combinations; Haloperidol; Humans; Lorazepam; Trihexypheni

1977
[The possibilities and limitations of psychotropic drug therapy for patients with glaucoma].
    Zhurnal nevropatologii i psikhiatrii imeni S.S. Korsakova (Moscow, Russia : 1952), 1974, Volume: 74, Issue:9

    Topics: Aged; Alcoholism; Amitriptyline; Antidepressive Agents; Bipolar Disorder; Chronic Disease; Dementia;

1974
Neurofibrillary tangles in progressive supranuclear palsy. Electron microscopic observations.
    Journal of neuropathology and experimental neurology, 1974, Volume: 33, Issue:1

    Topics: Aged; Amantadine; Brain; Brain Diseases; Bulbar Palsy, Progressive; Dementia; Dihydroxyphenylalanine

1974